comparemela.com
  1. Home
  2. Live Updates
  3. Michael Jon Pishvaian - Breaking News

Latest Breaking News On - Michael jon pishvaian - Page 1 : comparemela.com

RenovoRx, Inc : RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer

Company to Present Interim Analysis Secondary Endpoint Data Including Progression-free Survival from Phase III TIGeR-PaC Study, a Multi-center Open-label Study Evaluating RenovoGem to Treat Locally

United statesComunidad autonoma de catalunaMichael jon pishvaianShaun bagaiGewinn nurMichaelj pishvaianJack perkinsAmerican association of clinical researchClinical research programsassociate professor of oncologyCompany nasdaqStrategic communicationsSecurities exchangeWorld congress on gastrointestinal cancerJohn hopkins school of public healthExchange commissionRenovorx inc

RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer

Company to Present Interim Analysis Secondary Endpoint Data Including Progression-free Survival from Phase III TIGeR-PaC Study, a Multi-center Open-label Study Evaluating RenovoGem™ to Treat. | May 25, 2023

United statesComunidad autonoma de catalunaMichaelj pishvaianMichael jon pishvaianShaun bagaiCompany nasdaqSecurities exchangeWorld congress on gastrointestinal cancerClinical research programsAmerican association of clinical researchExchange commissionRenovorx incJohn hopkins school of public healthGastrointestinal cancerAmerican associationClinical research

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.